Summary: This month’s episode discusses the world’s first inhaled insulin by Pfizer named Exubera. My decision to use any new drug or delivery system includes three key areas and the final analysis always answers the question: “Do the benefits outweigh the risks?” If you wish to learn more or if you are considering inhaled insulin, this episode provides topics for starting a discussion with physicians and other medical professionals. Show notes: (1) Introduction (2) Intent of the Podcast Series (3) Legal Disclaimer (4) Health Concerns and Safety (5) Convenience (6) Personal Value (7) Conclusion (8) Building Block #5 (9) Next Month's Show (10 Feedback References used in producing this episode are located on the web page for this podcast.
